Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1861)
All Articles published online
|
Mar 14, 2007 (publication date) through Feb 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Midorikawa Y, Makuuchi M, Tang W, Aburatani H. Microarray-based analysis for hepatocellular carcinoma: From gene expression profiling to new challenges. World J Gastroenterol 2007; 13(10): 1487-1492 [PMID: 17461438 DOI: 10.3748/wjg.v13.i10.1487] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1487.htm |
| Number | Citing Articles |
| 1 |
Irena Ivanovska, Chunsheng Zhang, Angela M. Liu, Kwong F. Wong, Nikki P. Lee, Patrick Lewis, Ulrike Philippar, Dimple Bansal, Carolyn Buser, Martin Scott, Mao Mao, Ronnie T. P. Poon, Sheung Tat Fan, Michele A. Cleary, John M. Luk, Hongyue Dai, Wanjin Hong. Gene Signatures Derived from a c-MET-Driven Liver Cancer Mouse Model Predict Survival of Patients with Hepatocellular Carcinoma. PLoS ONE 2011; 6(9): e24582 doi: 10.1371/journal.pone.0024582
|
| 2 |
XIAOYUN ZENG, FUQIANG YIN, XIA LIU, JIANWEN XU, YANG XU, JINMEI HUANG, YUELI NAN, XIAOQIANG QIU. Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma. Oncology Reports 2014; 31(3): 1139 doi: 10.3892/or.2014.2968
|
| 3 |
|
| 4 |
Perumal Vivekanandan, Om V Singh. High-dimensional biology to comprehend hepatocellular carcinoma. Expert Review of Proteomics 2008; 5(1): 45 doi: 10.1586/14789450.5.1.45
|
| 5 |
P. Wang, L. Ouyang, L. Zheng, Z. Wang. Identifying hepatocellular carcinoma-related genes and pathways by system biology analysis. Irish Journal of Medical Science (1971 -) 2015; 184(2): 357 doi: 10.1007/s11845-014-1119-y
|
| 6 |
Emmanuelle Berger, Nathalie Vega, Michèle Weiss-Gayet, Alain Géloën. Gene Network Analysis of Glucose Linked Signaling Pathways and Their Role in Human Hepatocellular Carcinoma Cell Growth and Survival in HuH7 and HepG2 Cell Lines. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/821761
|
| 7 |
Omar Barakat, Patrick R. Wood, Claire F. Ozaki, Victor Ankoma-Sey, Joseph Galati, Mark Skolkin, Barry Toombs, Mary Round, Warren Moore, Luis Mieles. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: An intention-to-treat analysis. Liver Transplantation 2010; 16(3): 289 doi: 10.1002/lt.21994
|
| 8 |
Chiara Braconi, Nicola Valeri, Takayuki Kogure, Pierluigi Gasparini, Nianyuan Huang, Gerard J. Nuovo, Luigi Terracciano, Carlo M. Croce, Tushar Patel. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proceedings of the National Academy of Sciences 2011; 108(2): 786 doi: 10.1073/pnas.1011098108
|
| 9 |
Hirotaka Minagawa, Taro Yamashita, Masao Honda, Yo Tabuse, Kenichi Kamijo, Akira Tsugita, Shuichi Kaneko. Comparative Analysis of Proteome and Transcriptome in Human Hepatocellular Carcinoma using 2D-DIGE and SAGE. The Protein Journal 2008; 27(7-8): 409 doi: 10.1007/s10930-007-9123-y
|
| 10 |
Deshui Jia, Lin Wei, Weijie Guo, Ruopeng Zha, Meiyan Bao, Zhiao Chen, Yingjun Zhao, Chao Ge, Fangyu Zhao, Taoyang Chen, Ming Yao, Jinjun Li, Hongyang Wang, Jianren Gu, Xianghuo He. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma. Hepatology 2011; 54(4): 1227 doi: 10.1002/hep.24495
|
| 11 |
Samar Kamal Darweesh, Rasha Ahmed Abd Alziz, Heba Omar, Dina Sabry, Wael Fathy. Secreted protein acidic and rich in cysteine gene variants: Impact on susceptibility and survival of hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology 2019; 34(8): 1424 doi: 10.1111/jgh.14541
|
| 12 |
Justin T. Huntington, Xing Tang, Lindsey N. Kent, Carl R. Schmidt, Gustavo Leone. The Spectrum of E2F in Liver Disease-Mediated Regulation in Biology and Cancer. Journal of Cellular Physiology 2016; 231(7): 1438 doi: 10.1002/jcp.25242
|
| 13 |
Yoshikuni Inokawa, Kenichi Inaoka, Fuminori Sonohara, Masamichi Hayashi, Mitsuro Kanda, Shuji Nomoto. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncology Letters 2016; 12(5): 3662 doi: 10.3892/ol.2016.5141
|
| 14 |
David J. Brenner, Igor Shuryak, Rainer K. Sachs. ALERT - Adverse Late Effects of Cancer Treatment. Medical Radiology 2014; : 205 doi: 10.1007/978-3-540-72314-1_14
|
| 15 |
Xuedan Huang, Akiko Kojima-Yuasa, Shenghui Xu, David Opare Kennedy, Tadayoshi Hasuma, Isao Matsui-Yuasa. Combination of Zizyphus jujuba and Green Tea Extracts Exerts Excellent Cytotoxic Activity in HepG2 Cells via Reducing the Expression of APRIL. The American Journal of Chinese Medicine 2009; 37(01): 169 doi: 10.1142/S0192415X09006758
|
| 16 |
Hui-Zi Chen, Shih-Yin Tsai, Gustavo Leone. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nature Reviews Cancer 2009; 9(11): 785 doi: 10.1038/nrc2696
|
| 17 |
Ke Hao, John Lamb, Chunsheng Zhang, Tao Xie, Kai Wang, Bin Zhang, Eugene Chudin, Nikki P Lee, Mao Mao, Hua Zhong, Danielle Greenawalt, Mark D Ferguson, Irene O Ng, Pak C Sham, Ronnie T Poon, Cliona Molony, Eric E Schadt, Hongyue Dai, John M Luk. Clinicopathologic and gene expression parameters predict liver cancer prognosis. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-481
|
| 18 |
Hirotaka Minagawa, Masao Honda, Kenji Miyazaki, Yo Tabuse, Reiji Teramoto, Taro Yamashita, Ryuhei Nishino, Hajime Takatori, Teruyuki Ueda, Ken’ichi Kamijo, Shuichi Kaneko. Comparative proteomic and transcriptomic profiling of the human hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2008; 366(1): 186 doi: 10.1016/j.bbrc.2007.11.101
|
| 19 |
Mehmet Ender Avci, Ozlen Konu, Tamer Yagci. Quantification of SLIT-ROBO transcripts in hepatocellular carcinoma reveals two groups of genes with coordinate expression. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-392
|
| 20 |
Marc Ringelhan, Florian Reisinger, Detian Yuan, Achim Weber, Mathias Heikenwalder. Modeling Human Liver Cancer Heterogeneity: Virally Induced Transgenic Models and Mouse Genetic Models of Chronic Liver Inflammation. Current Protocols in Pharmacology 2014; 67(1) doi: 10.1002/0471141755.ph1431s67
|
| 21 |
M. Bellodi-Privato, M.S. Kubrusly, J.T. Stefano, I.C. Soares, A. Wakamatsu, A.C. Oliveira, V.A.F. Alves, T. Bacchella, M.C.C. Machado, L.A.C. D’Albuquerque. Differential gene expression profiles of hepatocellular carcinomas associated or not with viral infection. Brazilian Journal of Medical and Biological Research 2009; 42(12): 119 doi: 10.1590/S0100-879X2009005000037
|
| 22 |
Yutaka Midorikawa, Yasuyuki Sugiyama, Hiroyuki Aburatani. Screening of liver-targeted drugs. Expert Opinion on Drug Discovery 2008; 3(6): 643 doi: 10.1517/17460441.3.6.643
|
| 23 |
Ludovica Segat, Michele Milanese, Doroti Pirulli, Chiara Trevisiol, Francesco Lupo, Mauro Salizzoni, Antonio Amoroso, Sergio Crovella. Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients. Journal of Gastroenterology and Hepatology 2009; 24(12): 1840 doi: 10.1111/j.1440-1746.2009.06009.x
|
| 24 |
Jen-Eing Jeng, Jung-Fa Tsai, Lea-Yea Chuang, Mei-Shang Ho, Zu-Yau Lin, Min-Yuh Hsieh, Shin-Chern Chen, Wan-Lung Chuang, Liang-Yen Wang, Ming-Lung Yu, Chia-Yen Dai, Jan-Gowth Chang. Heat Shock Protein A1B 1267 Polymorphism Is Highly Associated With Risk and Prognosis of Hepatocellular Carcinoma. Medicine 2008; 87(2): 87 doi: 10.1097/MD.0b013e31816be95c
|
| 25 |
Yutaka Midorikawa, Yasuyuki Sugiyama, Hiroyuki Aburatani. Molecular targets for liver cancer therapy: From screening of target genes to clinical trials. Hepatology Research 2010; 40(1): 49 doi: 10.1111/j.1872-034X.2009.00583.x
|
| 26 |
Pelagia Foka, Aldo Pourchet, Ruben Hernandez‐Alcoceba, Polyxeni P. Doumba, George Pissas, Vlassis Kouvatsis, Georgia Dalagiorgou, Dorothea Kazazi, Peggy Marconi, Mariagiovanna Foschini, Roberto Manservigi, Manousos M. Konstadoulakis, John Koskinas, Alberto L. Epstein, Penelope Mavromara. Novel tumour‐specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors. The Journal of Gene Medicine 2010; 12(12): 956 doi: 10.1002/jgm.1519
|
| 27 |
Rajagopal N. Aravalli, Clifford J. Steer, Erik N. K. Cressman. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008; 48(6): 2047 doi: 10.1002/hep.22580
|
| 28 |
Xiaoli Zhou, Ruibin Li, Renwei Jing, Bingfeng Zuo, Quan Zheng. Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively. Journal of Cancer Research and Clinical Oncology 2020; 146(6): 1509 doi: 10.1007/s00432-020-03207-9
|
| 29 |
Ke Hao, John M Luk, Nikki PY Lee, Mao Mao, Chunsheng Zhang, Mark D Ferguson, John Lamb, Hongyue Dai, Irene O Ng, Pak C Sham, Ronnie TP Poon. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-389
|
| 30 |
Jia-Horng Kao, Pei-Jer Chen, Ding-Shinn Chen. . Advances in Cancer Research 2010; 108: 21 doi: 10.1016/B978-0-12-380888-2.00002-9
|
| 31 |
Nandan Dixit, Harsha Motwani, Hiteshkumar A. Solanki, Rakesh M. Rawal, Saumya K. Patel. Integrative bioinformatics analysis for the identification of hub genes and Virtual screening of phytochemicals to inhibit AURKA in HepatoCellular carcinoma. Human Gene 2024; 41: 201321 doi: 10.1016/j.humgen.2024.201321
|
| 32 |
P Meng, R Ghosh. Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?. Cell Death & Disease 2014; 5(8): e1360 doi: 10.1038/cddis.2014.326
|
| 33 |
Zhuang-Zhuang Zhang, Jian Huang, Yu-Ping Wang, Bing Cai, Ze-Guang Han. NOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma. International Journal of Cancer 2015; 137(4): 765 doi: 10.1002/ijc.29451
|
| 34 |
Kai Breuhahn, Gregory Gores, Peter Schirmacher. Strategies for hepatocellular carcinoma therapy and diagnostics: Lessons learned from high throughput and profiling approaches. Hepatology 2011; 53(6): 2112 doi: 10.1002/hep.24313
|